NCT01422655

Brief Summary

Objective: To assess the accuracy of transcutaneous bilirubin (TcB) measurements in neonates, in relation to gestational age (GA), time (postnatal hour) and site (forehead, sternum, knee) of measurements. Hypothesis: Using (or combining) different sites for TcB determination might improve the accuracy of TcB in relation to the time of measurement and the GA of the neonate. Methods: The study will include neonates \>32 weeks' gestation cared for in the well-baby nursery and NICU of the University Hospital of Patras, from September to December 2011. Data such as sex, gestational age, gestation and perinatal information, mother's and infant's ABO group and Rh, G6PD deficiency, Coombs test, type of delivery and complications, birthweight, postnatal medications and interventions, type and volume of feeding, and extension of jaundice, will be collected. TcB measurements will be performed using the BiliCheck bilirubinometer (according to the standard protocol) at 3 different sites: forehead, sternum and knee. Total serum bilirubin (TSB) values will be obtained using the heel stick technique, and measurements will be performed by a direct spectrophotometric device (Unistat bilirubinometer, Richert, Depew, NY). The accuracy of the device has been validated previously. TSB measurements will be performed within 5 minutes of the TcB measurements. At each occasion TcB measurements (3), the corresponding TSB value, the time of measurement (postnatal hours), and the actual weight will be noted. Statistics: The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The independent and joint effects of GA and time of measurement on bias will be evaluated by multivariate regression analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
255

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

August 22, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 24, 2011

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

January 24, 2012

Status Verified

January 1, 2012

Enrollment Period

5 months

First QC Date

August 22, 2011

Last Update Submit

January 22, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy characteristics of TcB as compared to TSB

    TcB measurements performed at 3 different sites (forehead, sternum, knee)will be compared with the corresponding TSB value. The agreement between TcB and TSB values will be assessed using the Bland-Altman % method. The effect of gestational age and time of measurement (postnatal hour)on TcB bias will be explored by multivariate regression analysis.

    Tcb vs TSB measurements at any time from birth to 120 postnatal hours

Eligibility Criteria

AgeUp to 120 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Term and preterm neonates from birth to 120 postnatal hours

You may qualify if:

  • Born at the University Hospital of Patras
  • GA \>32 weeks
  • Parental consent to participate

You may not qualify if:

  • Under phototherapy
  • Congenital infections
  • Chromosomal abnormalities
  • Congenital abnormalities
  • Hepatic dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neonatal Intensive Care Unit, University Hospital of Patras

Pátrai, 26504, Greece

Location

MeSH Terms

Conditions

Hyperbilirubinemia, Neonatal

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sotirios Fouzas, MD

    Neonatal Intensive Care Unit, University Hospital of Patras

    PRINCIPAL INVESTIGATOR
  • Anastasia Varvarigou, Prof

    Neonatal Intensive Care Unit, University Hospital of Patras

    STUDY DIRECTOR
  • Eugenia Panagiotopoulou, MD

    Neonatal Intensive Care Unit, University Hospital of Patras

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatrician, Neonatal Intensive Care Unit, University Hospital of Patras

Study Record Dates

First Submitted

August 22, 2011

First Posted

August 24, 2011

Study Start

August 1, 2011

Primary Completion

January 1, 2012

Study Completion

January 1, 2012

Last Updated

January 24, 2012

Record last verified: 2012-01

Locations